Kiril Aleksov Ahtarovski

Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial

Henning Kelbæk, Dan Eik Høfsten, Lars Køber et al. · The Lancet · 2016 · 203 citations

Percutaneous Coronary Intervention, Danami 3-Defer, Cardiovascular Disease +8

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial

Anna Axelsson Raja, Kasper Iversen, Niels Vejlstrup et al. · The Lancet Diabetes & Endocrinology · 2014 · 132 citations

Hypertension, Cardiomyopathy, Cardiovascular Disease +9

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction

Thomas Engstrøm, Henning Kelbæk, Steffen Helqvist et al. · JAMA Cardiology · 2017 · 127 citations · Full text

Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Lars Nepper‐Christensen, Jacob Lønborg, Kiril Aleksov Ahtarovski et al. · Journal of the American Heart Association · 2017 · 55 citations · Full text

Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study

Helle Petri, Kiril Aleksov Ahtarovski, Niels Vejlstrup et al. · Journal of Cardiovascular Magnetic Resonance · 2014 · 54 citations · Full text